Name: Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids (Video) | JoVE Journal
Uploaded: 2022-12-23T14:30:00.000+00:00
Duration: 10 min 43 s
Description: Learn to generate murine oral-esophageal 3D organoids modeling ESCC using 4NQO-treated mice. This protocol enables functional studies of tumor heterogeneity and therapeutic testing.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

We thank the Shared Resources (Flow Cytometry, Molecular Pathology, and Confocal &#38; Specialized Microscopy) at the Herbert Irving Comprehensive Cancer Center at Columbia University for technical support. We thank Drs. Alan Diehl, Adam J. Bass, and Kwok-Kin Wong (NCI P01 Mechanisms of Esophageal Carcinogenesis) and members of the Rustgi and Nakagawa laboratories for helpful discussions. This study was supported by the following NIH Grants: P01CA098101 (H.N. and A.K.R.), R01DK114436 (H.N.), R01AA026297 (H.N.), L30CA264714 (S.F.), DE031112-01 (F.M.H.), KL2TR001874 (F.M.H.),3R01CA255298-01S1 (J.G.), 2L30DK126621-02
(J.G.) R01CA266978 (C.L.), R01DK132251 (C.L.), R01DE031873 (C.L.), P30DK132710 (C.M. and H.N.), and P30CA013696 (A.K.R.). H.N. and C.L. are recipients of the Columbia University Herbert Irving Comprehensive Cancer Center Multi-PI Pilot Award. H.N. is a recipient of the Fanconi Anemia Research Fund Award. F.M.H. is the recipient of The Mark Foundation for Cancer Research Award (20-60-51-MOME) and an American Association for Cancer Research Award. J.G. is the recipient of the American Gastroenterological Association (AGA) award.

<ol><li>Rustgi, A. K., El-Serag, H. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Esophageal+carcinoma%5BTitle%5D)+AND+%22The+New+England+Journal+of+Medicine%22%5BJournal%5D)">Esophageal carcinoma.</a> The New England Journal of Medicine. 371 (26), 2499-2509 (2014).</li>
<li>Dotto, G. P., Rustgi, A. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Squamous+cell+cancers%3A+A+unified+perspective+on+biology+and+genetics%5BTitle%5D)+AND+%22Cancer+Cell%22%5BJournal%5D)">Squamous cell cancers: A unified perspective on biology and genetics.</a> Cancer Cell. 29 (5), 622-637 (2016).</li>
<li>Giroux, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Long-lived+keratin+15%2B+esophageal+progenitor+cells+contribute+to+homeostasis+and+regeneration%5BTitle%5D)+AND+%22The+Journal+of+Clinical+Investigation%22%5BJournal%5D)">Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regeneration.</a> The Journal of Clinical Investigation. 127 (6), 2378-2391 (2017).</li>
<li>DeWard, A. D., Cramer, J., Lagasse, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cellular+heterogeneity+in+the+mouse+esophagus+implicates+the+presence+of+a+nonquiescent+epithelial+stem+cell+population%5BTitle%5D)+AND+%22Cell+Reports%22%5BJournal%5D)">Cellular heterogeneity in the mouse esophagus implicates the presence of a nonquiescent epithelial stem cell population.</a> Cell Reports. 9 (2), 701-711 (2014).</li>
<li>Kinugasa, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mitochondrial+SOD2+regulates+epithelial-mesenchymal+transition+and+cell+populations+defined+by+differential+CD44+expression%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression.</a> Oncogene. 34 (41), 5229-5239 (2015).</li>
<li>Whelan, K. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Autophagy+supports+generation+of+cells+with+high+CD44+expression+via+modulation+of+oxidative+stress+and+Parkin-mediated+mitochondrial+clearance%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance.</a> Oncogene. 36 (34), 4843-4858 (2017).</li>
<li>Natsuizaka, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Interplay+between+Notch1+and+Notch3+promotes+EMT+and+tumor+initiation+in+squamous+cell+carcinoma%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma.</a> Nature Communications. 8 (1), 1758(2017).</li>
<li>Whelan, K. A., Muir, A. B., Nakagawa, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Esophageal+3D+culture+systems+as+modeling+tools+in+esophageal+epithelial+pathobiology+and+personalized+medicine%5BTitle%5D)+AND+%22Cellular+and+Molecular+Gastroenterology+and+Hepatology%22%5BJournal%5D)">Esophageal 3D culture systems as modeling tools in esophageal epithelial pathobiology and personalized medicine.</a> Cellular and Molecular Gastroenterology and Hepatology. 5 (4), 461-478 (2018).</li>
<li>Sachdeva, U. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Understanding+the+cellular+origin+and+progression+of+esophageal+cancer+using+esophageal+organoids%5BTitle%5D)+AND+%22Cancer+Letters%22%5BJournal%5D)">Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.</a> Cancer Letters. 509, 39-52 (2021).</li>
<li>Nakagawa, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+targeting+of+the+cyclin+D1+oncogene+by+an+Epstein-Barr+virus+promoter+in+transgenic+mice+causes+dysplasia+in+the+tongue%2C+esophagus+and+forestomach%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.</a> Oncogene. 14 (10), 1185-1190 (1997).</li>
<li>Andl, C. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Epidermal+growth+factor+receptor+mediates+increased+cell+proliferation%2C+migration%2C+and+aggregation+in+esophageal+keratinocytes+in+vitro+and+in+vivo%5BTitle%5D)+AND+%22The+Journal+of+Biological+Chemistry%22%5BJournal%5D)">Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo.</a> The Journal of Biological Chemistry. 278 (3), 1824-1830 (2003).</li>
<li>Opitz, O. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+mouse+model+of+human+oral-esophageal+cancer%5BTitle%5D)+AND+%22The+Journal+of+Clinical+Investigation%22%5BJournal%5D)">A mouse model of human oral-esophageal cancer.</a> The Journal of Clinical Investigation. 110 (6), 761-769 (2002).</li>
<li>Stairs, D. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Deletion+of+p120-catenin+results+in+a+tumor+microenvironment+with+inflammation+and+cancer+that+establishes+it+as+a+tumor+suppressor+gene%5BTitle%5D)+AND+%22Cancer+Cell%22%5BJournal%5D)">Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene.</a> Cancer Cell. 19 (4), 470-483 (2011).</li>
<li>Tang, X. -H., Knudsen, B., Bemis, D., Tickoo, S., Gudas, L. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Oral+cavity+and+esophageal+carcinogenesis+modeled+in+carcinogen-treated+mice%5BTitle%5D)+AND+%22Clinical+Cancer+Research%22%5BJournal%5D)">Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.</a> Clinical Cancer Research. 10, 301-313 (2004).</li>
<li>Fong, L. Y. Y., Mancini, R., Nakagawa, H., Rustgi, A. K., Huebner, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Combined+cyclin+D1+overexpression+and+zinc+deficiency+disrupts+cell+cycle+and+accelerates+mouse+forestomach+carcinogenesis%5BTitle%5D)+AND+%22Cancer+Research%22%5BJournal%5D)">Combined cyclin D1 overexpression and zinc deficiency disrupts cell cycle and accelerates mouse forestomach carcinogenesis.</a> Cancer Research. 63 (14), 4244-4252 (2003).</li>
<li>Zheng, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+new+murine+esophageal+organoid+culture+method+and+organoid-based+model+of+esophageal+squamous+cell+neoplasia%5BTitle%5D)+AND+%22iScience%22%5BJournal%5D)">A new murine esophageal organoid culture method and organoid-based model of esophageal squamous cell neoplasia.</a> iScience. 24 (12), 103440(2021).</li>
<li>Hisha, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Establishment+of+a+novel+lingual+organoid+culture+system%3A+generation+of+organoids+having+mature+keratinized+epithelium+from+adult+epithelial+stem+cells%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Establishment of a novel lingual organoid culture system: generation of organoids having mature keratinized epithelium from adult epithelial stem cells.</a> Scientific Reports. 3, 3224(2013).</li>
<li>Kalabis, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Isolation+and+characterization+of+mouse+and+human+esophageal+epithelial+cells+in+3D+organotypic+culture%5BTitle%5D)+AND+%22Nature+Protocols%22%5BJournal%5D)">Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture.</a> Nature Protocols. 7 (2), 235-246 (2012).</li>
<li>Nguyen, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((TGF-%CE%B21+alters+esophageal+epithelial+barrier+function+by+attenuation+of+claudin-7+in+eosinophilic+esophagitis%5BTitle%5D)+AND+%22Mucosal+Immunology%22%5BJournal%5D)">TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis.</a> Mucosal Immunology. 11 (2), 415-426 (2018).</li>
<li>Sherrill, J. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Analysis+and+expansion+of+the+eosinophilic+esophagitis+transcriptome+by+RNA+sequencing%5BTitle%5D)+AND+%22Genes+and+Immunity%22%5BJournal%5D)">Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing.</a> Genes and Immunity. 15 (6), 361-369 (2014).</li>
<li>Ruffner, M. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Toll-like+receptor+2+stimulation+augments+esophageal+barrier+integrity%5BTitle%5D)+AND+%22Allergy%22%5BJournal%5D)">Toll-like receptor 2 stimulation augments esophageal barrier integrity.</a> Allergy. 74 (12), 2449-2460 (2019).</li>
<li>Kabir, M. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Single+cell+transcriptomic+analysis+reveals+cellular+diversity+of+murine+esophageal+epithelium%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">Single cell transcriptomic analysis reveals cellular diversity of murine esophageal epithelium.</a> Nature Communications. 13 (1), 1-15 (2022).</li>
<li>Shimonosono, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Alcohol+metabolism+enriches+squamous+cell+carcinoma+cancer+stem+cells+that+survive+oxidative+stress+via+autophagy%5BTitle%5D)+AND+%22Biomolecules%22%5BJournal%5D)">Alcohol metabolism enriches squamous cell carcinoma cancer stem cells that survive oxidative stress via autophagy.</a> Biomolecules. 11 (10), 1479(2021).</li>
<li>Flashner, S., Yan, K. S., Nakagawa, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((3D+organoids%3A+An+untapped+platform+for+studying+host-microbiome+interactions+in+esophageal+cancers%5BTitle%5D)+AND+%22Microorganisms%22%5BJournal%5D)">3D organoids: An untapped platform for studying host-microbiome interactions in esophageal cancers.</a> Microorganisms. 9 (11), 2182(2021).</li>
<li>Liu, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Sox2+cooperates+with+inflammation-mediated+stat3+activation+in+the+malignant+transformation+of+foregut+basal+progenitor+cells%5BTitle%5D)+AND+%22Cell+Stem+Cell%22%5BJournal%5D)">Sox2 cooperates with inflammation-mediated stat3 activation in the malignant transformation of foregut basal progenitor cells.</a> Cell Stem Cell. 12 (3), 304-315 (2013).</li>
</ol>

The authors declare no conflicts of interest.

&#160; &#160; &#160;There are several critical steps and considerations for the generation and analysis of MEOs in the protocols described here. To ensure reproducibility and rigor in MEO experiments, biological and technical replicates are both important. For biological replicates, two to three independent mice bearing ESCC are generally sufficient per experimental condition. However, the appropriate number of biological replicates may vary depending on the parameters to be tested in individual studies. For example, it ...

Esophageal squamous cell carcinoma (ESCC) is the deadliest of human squamous cell carcinomas, owing to its late diagnosis, therapy resistance, and metastasis1,2. ESCC arises from the stratified squamous epithelium, which lines the luminal surface of the esophagus. The squamous epithelium is comprised of proliferative basal cells and differentiated cells within the suprabasal cell layer. Under physiologic conditions, basal cells express markers such as p63, Sox2, and cytokeratin K5 and K14, while differentiated cells express K4, K13, and IVL. Basal cells themselves are heterogeneous and include putative stem cells defined by markers such as K153 and CD734. In homeostasis, basal cells undergo post-mitotic terminal differentiation within the suprabasal cell layer, whereas differentiated cells migrate and desquamate into the lumen to complete epithelial renewal. Reminiscent of their cells of origin, ESCC displays squamous cell differentiation to varying degrees. ESCC is often accompanied by multifocal histologic precursor lesions, known as intraepithelial neoplasia (IEN) or dysplasia, comprising atypical basaloid cells. In addition to epithelial changes, ESCC displays tissue remodeling within the subepithelial compartment, where the activation of cancer-associated fibroblasts (CAFs) and the recruitment of immune/inflammatory cells take place to foster the tumor-promoting microenvironment.
The pathogenesis of ESCC involves genetic changes and exposure to environmental risk factors. Key genetic lesions include the inactivation of the tumor suppressor genes TP53 and CDKN2A (p16INK4A) and the activation of the CCND1 (cyclin D1) and EGFR oncogenes, which culminate in impaired cell cycle checkpoint function, aberrant proliferation, and survival under genotoxic stress related to exposure to environmental carcinogens. Indeed, genetic changes interact closely with behavioral and environmental risk factors, most commonly tobacco and alcohol use. Tobacco smoke contains human carcinogens such as acetaldehyde, which is also the major metabolite of alcohol. Acetaldehyde induces DNA adducts and interstrand DNA crosslinks, leading to DNA damage and the accumulation of DNA mutations and chromosomal instability. Given excessive mitogenic stimuli and aberrant proliferation from oncogene activation, the malignant transformation of esophageal epithelial cells is facilitated by mechanisms to cope with genotoxic stress, including the activation of antioxidants, autophagy, and epithelial-mesenchymal transition (EMT). Interestingly, these cytoprotective functions are often activated in ESCC cancer stem cells (CSCs) that are characterized by high CD44 (CD44H) expression and have the capabilities of tumor initiation, invasion, metastasis, and therapy resistance5,6,7.
ESCC has been modeled in cell culture and in rodent models8,9. In the last three decades, robust genetically engineered mouse models of ESCC have been developed. These include CCND1 and EGFR transgenic mice10,11 and p53 and p120Ctn knockout mice12,13. However, single genetic changes do not typically result in rapid-onset ESCC. This challenge has been overcome with the use of esophageal carcinogens that recapitulate well the human genetic lesions in ESCC14. For example, 4-nitroquinoline-1-oxide (4NQO) accelerates ESCC development in CCND1 transgenic mice15. In recent years, putative esophageal epithelial stem cells, progenitor cells, and their respective fates have been investigated in cell lineage-traceable mouse models3,4. Furthermore, these cell lineage-traceable mice have been utilized to explore the cells of origin of ESCC and how such cells give rise to CD44H CSCs via conventional histology and omics-based molecular characterization7.
One emerging area related to these mouse models is the novel application of cell culture techniques to analyze live ESCC and precursor cells in a three-dimensional (3D) organoid system in which the architecture of the original tissues is recapitulated ex vivo7,8,9. These 3D organoids are rapidly grown from a single-cell suspension isolated from murine tissues, including primary and metastatic tumors (e.g., lymph node, lung, and liver lesions). The cells are embedded in basement membrane extract (BME) and fed with a well-defined serum-free cell culture medium. The 3D organoids grow within 7-10 days, and the resulting spherical structures are amenable for subculture, cryopreservation, and assays for analyzing a variety of cellular properties and functions, including CSC markers, EMT, autophagy, proliferation, differentiation, and apoptotic cell death.
These methods can be broadly applied to 3D organoid cultures established from any stratified squamous epithelial tissue, such as the head and neck mucosa (oral cavity, tongue, pharynx, and larynx) and even the forestomach. The head and neck mucosa are contiguous with the esophagus, and the two tissues share similar tissue organization, function, and susceptibility to disease. Both head and neck squamous cell carcinoma (HNSCC) and ESCC share genetic lesions and lifestyle-related environmental risk factors such as tobacco and alcohol exposure. Underscoring this similarity, mice treated with the tobacco smoke mimetic 4NQO readily develop both HNSCC and ESCC. Given the ease with which the protocols described below can be applied to modeling HNSCC, we include specific instructions for establishing 3D organoid cultures from these lesions.
Herein, we provide detailed protocols for generating murine esophageal 3D organoids (MEOs) representing normal, preneoplastic, and ESCC lesions that develop in mice treated with 4NQO. Various mouse strains can be utilized, including common laboratory strains such as C57BL/6 and cell lineage-traceable and other genetically engineered derivatives. We emphasize the key steps, including the isolation of normal or diseased murine esophageal epithelium, the preparation of single-cell suspensions, the cultivation and monitoring of the growing 3D organoids, subculture, cryopreservation, and the processing for subsequent analyses, including morphology and other applications.

<table><tbody><tr><td>0.05% trypsin-EDTA</td><td>Thermo Fisher Scientific</td><td>25-300-120</td><td></td></tr><tr><td>0.25% trypsin-EDTA</td><td>Thermo Fisher Scientific</td><td>25-200-114</td><td></td></tr><tr><td>0.4% Trypan Blue</td><td>Thermo Fisher Scientific</td><td>T10282</td><td></td></tr><tr><td>1 mL tuberculin syringe without needle</td><td>BD</td><td>309659</td><td></td></tr><tr><td>1.5 mL microcentrifuge tube</td><td>Thermo Fisher Scientific</td><td>05-408-129</td><td></td></tr><tr><td>100 &amp;micro;m cell strainer</td><td>Thermo Fisher Scientific</td><td>22363549</td><td></td></tr><tr><td>15 mL conical tubes</td><td>Thermo Fisher Scientific</td><td>14-959-53A</td><td></td></tr><tr><td>200 &amp;micro;L wide bore micropipette tips</td><td>Thermo Fisher Scientific</td><td>212361A</td><td></td></tr><tr><td>21 G needles</td><td>BD</td><td>305167</td><td></td></tr><tr><td>24 well plate</td><td>Thermo Fisher Scientific</td><td>12-556-006</td><td></td></tr><tr><td>4-Nitroquinoline-1-oxide (4NQO)</td><td>Tokyo Chemical Industry</td><td>NO250</td><td></td></tr><tr><td>50 mL conical tubes</td><td>Thermo Fisher Scientific</td><td>12-565-270</td><td></td></tr><tr><td>6 well plate</td><td>Thermo Fisher Scientific</td><td>12556004</td><td></td></tr><tr><td>70 &amp;micro;m cell strainer</td><td>Thermo Fisher Scientific</td><td>22363548</td><td></td></tr><tr><td>99.9% ethylene propylene glycol</td><td>SK picglobal</td><td></td><td></td></tr><tr><td>Advanced DMEM/F12</td><td>Thermo Fisher Scientific</td><td>12634028</td><td></td></tr><tr><td>Amphotericin B</td><td>Gibco, Thermo Fisher Scientific</td><td>15290018</td><td>Stock concentration 250 &amp;micro;g/mL, final concentration 0.5 &amp;micro;g/mL</td></tr><tr><td>Antibiotic-Antimycotic</td><td>Thermo Fisher Scientific</td><td>15240062</td><td>Stock concentration 100x, final concentration 1x</td></tr><tr><td>B-27 supplement</td><td>Thermo Fisher Scientific</td><td>17504044</td><td>Stock concentration 50x, final concentration 1x</td></tr><tr><td>Bacto agar</td><td>BD</td><td>214010</td><td></td></tr><tr><td>CO&lt;sub&gt;2 &lt;/sub&gt;incubator, e.g.Heracell 150i</td><td>Thermo Fisher Scientific</td><td>51026406</td><td>or equivalent</td></tr><tr><td>Countess II FL Automated Cell Counter</td><td>Thermo Fisher Scientific</td><td>AMQAX1000</td><td>or equivalent</td></tr><tr><td>Cryovials</td><td>Thermo Fisher Scientific</td><td>03-337-7D</td><td></td></tr><tr><td>DietGel 76A</td><td>Clear H2O</td><td>72-07-5022</td><td></td></tr><tr><td>Dimethyl sulfoxide (DMSO)</td><td>MilliporeSigma</td><td>D4540</td><td></td></tr><tr><td>Dispase</td><td>Corning</td><td>354235</td><td>Stock concentration 50 U/mL, final concentration 2.5&amp;ndash;5 U/mL</td></tr><tr><td>Dissecting scissors</td><td>VWR</td><td>25870-002</td><td></td></tr><tr><td>Dulbecco&#039;s phosphate-buffered saline (PBS)</td><td>Thermo Fisher Scientific</td><td>14190250</td><td>Stock concentration 1x</td></tr><tr><td>Fetal bovine serum (FBS)</td><td>HyClone</td><td>SH30071.03</td><td></td></tr><tr><td>Forceps</td><td>VWR</td><td>82027-386</td><td></td></tr><tr><td>Freezing container</td><td>Corning</td><td>432002</td><td>or equivalent</td></tr><tr><td>Gelatin</td><td>Thermo Fisher Scientific</td><td>G7-500</td><td></td></tr><tr><td>GlutaMAX</td><td>Thermo Fisher Scientific</td><td>35050061</td><td>Stock concentration 100x, final concentration 1x</td></tr><tr><td>HEPES</td><td>Thermo Fisher Scientific</td><td>15630080</td><td>Stock concentration 1 M, final concentration 10 mM</td></tr><tr><td>Hot plate/stirrer</td><td>Corning</td><td>PC-420D</td><td>or equivalent</td></tr><tr><td>Lab Armor bead bath (or water bath)</td><td>VWR</td><td>89409-222</td><td>or equivalent</td></tr><tr><td>Laboratory balance</td><td>Ohaus</td><td>71142841</td><td>or equivalent</td></tr><tr><td>Matrigel basement membrane extract (BME)</td><td>Corning</td><td>354234</td><td></td></tr><tr><td>Microcentrifuge Minispin</td><td>Eppendorf</td><td>22620100</td><td>or equivalent</td></tr><tr><td>Microcentrifuge tube rack</td><td>Southern Labware</td><td>0061</td><td></td></tr><tr><td>N-2 supplement</td><td>Thermo Fisher Scientific</td><td>17502048</td><td>Stock concentration 100x, final concentration 1x</td></tr><tr><td>N-acetylcysteine (NAC)</td><td>Sigma-Aldrich</td><td>A9165</td><td>Stock concentration 0.5 M, final concentration 1 mM</td></tr><tr><td>Parafilm M wrap</td><td>Thermo Fisher Scientific</td><td>S37440</td><td></td></tr><tr><td>Paraformaldehyde (PFA)</td><td>MilliporeSigma</td><td>158127-500G</td><td></td></tr><tr><td>Pathology cassette</td><td>Thermo Fisher Scientific</td><td>22-272416</td><td></td></tr><tr><td>Phase-contrast microscope</td><td>Nikon</td><td></td><td>or equivalent</td></tr><tr><td>Recombinant mouse epidermal growth factor (mEGF)</td><td>Peprotech</td><td>315-09-1mg</td><td>Stock concentration 500 ng/&amp;micro;L, final concentration 100 ng/mL</td></tr><tr><td>RN cell-conditioned medium expressing R-Spondin1 and Noggin (RN CM)</td><td>N/A</td><td>N/A</td><td>Available through the Organoid and Cell Culture Core upon request, final concentration 2%</td></tr><tr><td>Sorval ST 16R centrifuge</td><td>Thermo Fisher Scientific</td><td>75004380</td><td>or equivalent</td></tr><tr><td>Soybean trypsin inhibitor (STI)</td><td>MilliporeSigma</td><td>T9128</td><td>Stock concentration 250 &amp;micro;g/mL</td></tr><tr><td>ThermoMixer C</td><td>Thermo Fisher Scientific</td><td>14-285-562 PM</td><td>or equivalent</td></tr><tr><td>Y-27632</td><td>Selleck Chemicals</td><td>S1049</td><td>Stock concentration 10 mM, final concentration 10 &amp;micro;M</td></tr></tbody></table>

modeling oral-esophageal squamous cell carcinoma in 3d organoids

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Esophageal squamous cell carcinoma (ESCC) is prevalent worldwide, accounting for 90% of all esophageal cancer cases each year, and is the deadliest of all human squamous cell carcinomas. Despite recent progress in defining the molecular changes accompanying ESCC initiation and development, patient prognosis remains poor. The functional annotation of these molecular changes is the necessary next step and requires models that both capture the molecular features of ESCC and can be readily and inexpensively manipulated for functional annotation. Mice treated with the tobacco smoke mimetic 4-nitroquinoline 1-oxide (4NQO) predictably form ESCC and esophageal preneoplasia. Of note, 4NQO lesions also arise in the oral cavity, most commonly in the tongue, as well as the forestomach, which all share the stratified squamous epithelium. However, these mice cannot be simply manipulated for functional hypothesis testing, as generating isogenic mouse models is time- and resource-intensive. Herein, we overcome this limitation by generating single cell-derived three-dimensional (3D) organoids from mice treated with 4NQO to characterize murine ESCC or preneoplastic cells ex vivo. These organoids capture the salient features of ESCC and esophageal preneoplasia, can be cheaply and quickly leveraged to form isogenic models, and can be utilized for syngeneic transplantation experiments. We demonstrate how to generate 3D organoids from normal, preneoplastic, and SCC murine esophageal tissue and maintain and cryopreserve these organoids. The applications of these versatile organoids are broad and include the utilization of genetically engineered mice and further characterization by flow cytometry or immunohistochemistry, the generation of isogeneic organoid lines using CRISPR technologies, and drug screening or syngeneic transplantation. We believe that the widespread adoption of the techniques demonstrated in this protocol will accelerate progress in this field to combat the severe burden of ESCC.

This protocol describes the process of generating murine esophageal organoids (MEOs) from normal esophageal tissue or ESCC tumor tissue from 4NQO-treated mice according to a specific treatment regimen consisting of 16 weeks of 4NQO administered in drinking water, followed by a 10 week to 12 week observation period (Figure 1). The mice are then euthanized for the dissection of the tongue or esophageal tissue (Figure 2 and Figure 3). ...

This protocol describes the key steps to generate and characterize murine oral-esophageal 3D organoids that represent normal, preneoplastic, and squamous cell carcinoma lesions induced via chemical carcinogenesis.

Esophageal squamous cell carcinoma (ESCC) is prevalent worldwide, accounting for 90% of all esophageal cancer cases each year, and is the deadliest of all ...

modeling-oral-esophageal-squamous-cell-carcinoma-in-3d-organoids

Research

JoVE Journal

Cancer Research

A comprehensive overview of the techniques involved in generating a mouse model of oral cancer and quantitative monitoring of tumor invasion within the tongue through multi-photon microscopy of labeled cells is presented.  This system can serve as a useful platform for the molecular assessment and drug efficacy of anti-invasive compounds.

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Organoids derived from tumors are a type of 3D cell culture model that can maintain the pathological features and organ-specific cell lineage of tumors. In the example protocol, we will see scientists generate organoids from a prostate tumor from a genetically engineered mouse model.

Preparing Organoids from Tumors: A 3D In Vitro Tumor Model

This video describes an in vitro culture technique to generate human organotypic esophageal constructs by co-culturing primary human esophageal fibroblast and squamous epithelial cells within a decellularized porcine scaffold. These 3D culture models mimic the function and physiology of their in vivo tissue counterparts.

Esophageal 3D Raft Culture Model: An In Vitro Culture Technique to Generate Human Esophageal Mucosa Model

This manuscript describes the production, characterization and potential uses of a tissue engineered 3D esophageal construct prepared from normal primary human esophageal fibroblast and squamous epithelial cells seeded within a de-cellularized porcine scaffold. The results demonstrate the formation of a mature stratified epithelium similar to the normal human esophagus.

Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model

Here, we present a protocol to generate a 3D organotypic melanoma spheroid skin model that recapitulates both the architecture and multicellular complexity of an organ/tumor in vivo but at the same time accommodates systematic experimental intervention.

A 3D Organotypic Melanoma Spheroid Skin Model

An in vitro model system was developed to capture tissue architectural changes during lung squamous carcinoma (LUSC) progression in a 3-dimensional (3D) co-culture with cancer-associated fibroblasts (CAFs). This organoid system provides a unique platform to investigate the roles of diverse tumor cell-intrinsic and extrinsic changes that modulate the tumor phenotype.

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

The article describes step wise directed differentiation of induced pluripotent stem cells to three-dimensional whole lung organoids containing both proximal and distal epithelial lung cells along with mesenchyme.

Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease

This protocol describes the methods of subculture and cryopreservation of esophageal adenocarcinoma organoids with and without single cell digestion to enable researchers to choose appropriate strategies based on their experimental design.

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion

This protocol discusses an approach for generating epithelial organoids from primary normal and tumor mammary tissue through differential centrifugation. Furthermore, instructions are included for three-dimensional culturing as well as immunofluorescent imaging of embedded organoids.

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Organoid-fibroblast co-cultures provide a model to study the in vivo stem cell niche. Here, a protocol for esophageal organoid-fibroblast co-cultures is described. Additionally, whole mount imaging is used to visualize the fibroblast-organoid interaction.

Functional Characterization and Visualization of Esophageal Fibroblasts Using Organoid Co-Cultures

The present protocol describes the establishment and histological analysis of esophageal organoid models that represent different stages of tumor progression. This method enables researchers to study changes in cellular morphology, spatial organization, and molecular marker expression patterns during the transition from normal to cancerous tissues.

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Learn to generate murine oral-esophageal 3D organoids modeling ESCC using 4NQO-treated mice. This protocol enables functional studies of tumor heterogeneity and therapeutic testing.

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Explore More Videos